Epidemiology and Mortality Predictors for Severe Childhood Community-acquired Pneumonia in ICUs: A Retrospective Observational Study

Overview

Journal Front Pediatr

Specialty Pediatrics

Date 2023 Apr 10

PMID 37033191

Authors

Lu Cao

Zhaohua Ji

Peng Zhang

Jingwen Wang

Affiliations

Soon will be listed here.

Abstract

Background: To identify the epidemiology and mortality predictors of severe childhood community-acquired pneumonia (CAP) and evaluate the influence of medications on clinical outcomes in the real world.

Methods: We conducted a multicenter retrospective observational study among children aged ≤5 years with severe CAP, separately comparing the detailed information between those who experienced in-hospital death and those who survived in three different age groups. A multivariate logistic regression model was used to determine mortality predictors.

Results: A total of 945 children were recruited: 341 young children aged 2-59 months, 47 infants aged 29 days to 2 months, and 557 neonates aged less than 28 days. A total of 88 deaths occurred (9.3%). There was low adherence to antimicrobial guidelines in the group aged 2-59 months, and carbapenems widely served as initial empirical regimens. However, analysis of all three age groups showed that the efficacy of antibacterial drugs with initial empirical selection grades higher than those recommended by the guidelines was not better than that of antibacterial drugs with grades recommended by the guidelines. In multivariate analyses, very severe pneumonia (odds ratio (OR): 3.48; 95% confidence interval (CI): 1.36-8.93), lower birth weight (OR: 4.64; 95% CI: 1.78-12.20), severe underweight (OR: 6.06; 95% CI: 2.34-15.63), mechanical ventilation (OR: 2.58; 95% CI: 1.00-6.62; OR: 15.63; 95% CI 3.25-76.92), a higher number of comorbidities (OR: 8.40; 95% CI: 1.89-37.04), comorbidities including anemia (OR: 5.24; 95% CI: 2.33-11.76) and gastrointestinal hemorrhage (OR: 3.79; 95% CI: 1.36-10.53), and the use of sedative-hypnotics (OR: 2.60; 95% CI: 1.14-5.95) were independent risk factors for death; infants treated with probiotics had a lower mortality rate (OR: 0.14; 95% CI: 0.06-0.33).

Conclusions: Severe CAP remains a primary cause of death in children under 5 years of age. Clinical characteristics, comorbidities and medications are evidently associated with death. Importantly, we should pay particular attention to the identification of mortality predictors and establish prophylactic measures to reduce mortality.

Citing Articles

Diagnostic value of miR-193a-5p in severe pneumonia and its correlation with prognosis.

Su X, Zhu L, Zhuo J, Zhang S J Cardiothorac Surg. 2025; 20(1):87.

PMID: 39849492 PMC: 11756221. DOI: 10.1186/s13019-024-03256-y.

Dynamics of platelet parameters in children with severe community-acquired pneumonia between viral and bacterial infections.

Fan C, Mao Y, Liu J, Gao H, Fang B, Li R Transl Pediatr. 2024; 13(1):52-62.

PMID: 38323174 PMC: 10839274. DOI: 10.21037/tp-23-441.

Effect of probiotics intake on constipation in children: an umbrella review.

Dong M, Wu Y, Zhang M, Chen P, Zhang Z, Wang S Front Nutr. 2023; 10:1218909.

PMID: 37720380 PMC: 10502344. DOI: 10.3389/fnut.2023.1218909.

References

Rashid M, Chisti M, Akter D, Sarkar M, Chowdhury F . Antibiotic use for pneumonia among children under-five at a pediatric hospital in Dhaka city, Bangladesh. Patient Prefer Adherence. 2017; 11:1335-1342. PMC: 5548281. DOI: 10.2147/PPA.S140002. View

McLean E, Cogswell M, Egli I, Wojdyla D, de Benoist B . Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993-2005. Public Health Nutr. 2008; 12(4):444-54. DOI: 10.1017/S1368980008002401. View

Williams D, Edwards K, Self W, Zhu Y, Ampofo K, Pavia A . Antibiotic Choice for Children Hospitalized With Pneumonia and Adherence to National Guidelines. Pediatrics. 2015; 136(1):44-52. PMC: 4485005. DOI: 10.1542/peds.2014-3047. View

Curbelo J, Luquero Bueno S, Galvan-Roman J, Ortega-Gomez M, Rajas O, Fernandez-Jimenez G . Inflammation biomarkers in blood as mortality predictors in community-acquired pneumonia admitted patients: Importance of comparison with neutrophil count percentage or neutrophil-lymphocyte ratio. PLoS One. 2017; 12(3):e0173947. PMC: 5354424. DOI: 10.1371/journal.pone.0173947. View

McAllister D, Liu L, Shi T, Chu Y, Reed C, Burrows J . Global, regional, and national estimates of pneumonia morbidity and mortality in children younger than 5 years between 2000 and 2015: a systematic analysis. Lancet Glob Health. 2018; 7(1):e47-e57. PMC: 6293057. DOI: 10.1016/S2214-109X(18)30408-X. View

Thomson J, Ambroggio L, Kurowski E, Statile A, Graham C, Courter J . Hospital outcomes associated with guideline-recommended antibiotic therapy for pediatric pneumonia. J Hosp Med. 2014; 10(1):13-8. PMC: 4322863. DOI: 10.1002/jhm.2265. View

Smit E, Odd D, Whitelaw A . Postnatal phenobarbital for the prevention of intraventricular haemorrhage in preterm infants. Cochrane Database Syst Rev. 2013; (8):CD001691. PMC: 7061244. DOI: 10.1002/14651858.CD001691.pub3. View

Akcay N, Kihtir H, Durak C, Kendirli T, Havan M, Kockuzu E . Mortality Risk Factors Among Critically Ill Children With Acute COVID-19 in PICUs: A Multicenter Study From Turkish Pediatric Critical COVID-19 and MIS-C Study Group. Pediatr Infect Dis J. 2022; 41(9):742-750. PMC: 9359682. DOI: 10.1097/INF.0000000000003592. View

Wen B, Brals D, Bourdon C, Erdman L, Ngari M, Chimwezi E . Predicting the risk of mortality during hospitalization in sick severely malnourished children using daily evaluation of key clinical warning signs. BMC Med. 2021; 19(1):222. PMC: 8451091. DOI: 10.1186/s12916-021-02074-6. View

10.

McIntosh K . Community-acquired pneumonia in children. N Engl J Med. 2002; 346(6):429-37. DOI: 10.1056/NEJMra011994. View

11.

Enarson P, Gie R, Mwansambo C, Chalira A, Lufesi N, Maganga E . Potentially Modifiable Factors Associated with Death of Infants and Children with Severe Pneumonia Routinely Managed in District Hospitals in Malawi. PLoS One. 2015; 10(8):e0133365. PMC: 4523211. DOI: 10.1371/journal.pone.0133365. View

12.

Ferreira S, SantAnna C, March M, Santos M, Cunha A . Lethality by pneumonia and factors associated to death. J Pediatr (Rio J). 2013; 90(1):92-7. DOI: 10.1016/j.jped.2013.05.008. View

13.

Jroundi I, Mahraoui C, Benmessaoud R, Moraleda C, Tligui H, Seffar M . Risk factors for a poor outcome among children admitted with clinically severe pneumonia to a university hospital in Rabat, Morocco. Int J Infect Dis. 2014; 28:164-70. PMC: 7129557. DOI: 10.1016/j.ijid.2014.07.027. View

14.

Del Piano M, Coggiola F, Pane M, Amoruso A, Nicola S, Mogna L . Can Probiotics Reduce Diarrhea and Infant Mortality in Africa?: The Project of a Pilot Study. J Clin Gastroenterol. 2016; :S120-S123. DOI: 10.1097/MCG.0000000000000677. View

15.

Biswal N, Narayanan P, Srinivasaraghavan R, Banupriya B . Probiotic prophylaxis to prevent ventilator-associated pneumonia (VAP) in children on mechanical ventilation: an open-label randomized controlled trial--response to comments by Saptharishi et al. Intensive Care Med. 2015; 41(6):1162-3. DOI: 10.1007/s00134-015-3823-0. View

16.

Queen M, Myers A, Hall M, Shah S, Williams D, Auger K . Comparative effectiveness of empiric antibiotics for community-acquired pneumonia. Pediatrics. 2013; 133(1):e23-9. PMC: 4535024. DOI: 10.1542/peds.2013-1773. View

17.

Krauss B, Andolfatto G, Krauss B, Mieloszyk R, Monuteaux M . Characteristics of and Predictors for Apnea and Clinical Interventions During Procedural Sedation. Ann Emerg Med. 2016; 68(5):564-573. DOI: 10.1016/j.annemergmed.2016.07.010. View

18.

Liu K, Zhu Y, Zhang J, Tao L, Lee J, Wang X . Probiotics' effects on the incidence of nosocomial pneumonia in critically ill patients: a systematic review and meta-analysis. Crit Care. 2012; 16(3):R109. PMC: 3580667. DOI: 10.1186/cc11398. View

19.

Caggiano S, Ullmann N, De Vitis E, Trivelli M, Mariani C, Podagrosi M . Factors That Negatively Affect the Prognosis of Pediatric Community-Acquired Pneumonia in District Hospital in Tanzania. Int J Mol Sci. 2017; 18(3). PMC: 5372637. DOI: 10.3390/ijms18030623. View

20.

Menendez R, Torres A, Reyes S, Zalacain R, Capelastegui A, Aspa J . Initial management of pneumonia and sepsis: factors associated with improved outcome. Eur Respir J. 2011; 39(1):156-62. DOI: 10.1183/09031936.00188710. View